Recombinant Human Eotaxin
| Code | Size | Price |
|---|
| LEI-E196-20ug | 20 ug | £307.00 |
Quantity:
| LEI-E196-100ug | 100 ug | £625.00 |
Quantity:
| LEI-E196-500ug | 500 ug | £2,395.00 |
Quantity:
| LEI-E196-1.0mg | 1 mg | £4,278.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Further Information
Format:
This protein was lyophilized from a sterile filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA).
Formulation:
This protein was lyophilized from a sterile filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA).
Long Description:
The CC-chemokine eotaxin is a potent eosinophil chemoattractant that stimulates recruitment of eosinophils from the blood to sites of allergic inflammation.1 Eotaxin and related molecules are potentially important endogenous signaling substances in allergic reactions.2 Eotaxin plays an important role not only by attracting eosinophils to the site of inflammation but also by damaging tissue by its capacity to induce the release of reactive oxygen species.3
Purity:
?95% by SDS Page
Target:
Eotaxin
References
1. Rankin SM. et al. (1998) Blood. 91:2240
2. Williams TJ. et al. (1993) Biochem Biophys Res Commun. 197:1167
3. Kapp A. et al. (1996) Eur J Immunol. 26:1919
Related Products
| Product Name | Product Code | Supplier | Anti-Human Eotaxin | LEI-C1397 | Leinco Technologies | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human Eotaxin (CT) | LEI-E182 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eotaxin Blocking Peptide | LEI-E183 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Mouse Eotaxin | LEI-E202 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Eotaxin ELISA Development Kit | LEI-E304 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mouse Eotaxin ELISA Development Kit | LEI-E306 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||